Sunny Pharmtech Inc. (TPEX:6676)
11.15
-0.30 (-2.62%)
Sep 15, 2026, 1:34 PM CST
Sunny Pharmtech Market Cap
Sunny Pharmtech has a market cap or net worth of 1.94 billion as of September 14, 2026. Its market cap has decreased by -27.47% in one year.
Market Cap
1.94B
Enterprise Value
2.18B
Revenue
233.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
11.15
ChartMarket Cap Chart
Since January 19, 2022, Sunny Pharmtech's market cap has decreased from 3.26B to 1.94B, a decrease of -40.45%. That is a compound annual growth rate of -10.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 1.55B | -25.27% |
| Dec 31, 2025 | 2.08B | -36.99% |
| Dec 31, 2024 | 3.29B | -35.60% |
| Dec 29, 2023 | 5.12B | 87.02% |
| Dec 30, 2022 | 2.74B | -16.14% |
| Jan 19, 2022 | 3.26B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GlycoNex Incorporation | 2.45B |
| 3D Global Biotech | 2.38B |
| Taiwan Bio Therapeutics | 2.33B |
| Sunhawk Vision Biotech | 2.28B |
| Syngen Biotech | 2.13B |
| HeXun Biosciences | 2.11B |
| Anti-Microbial Savior BioteQ | 1.98B |
| Gwo Xi Stem Cell Applied Technology Co. , | 1.97B |